← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2007Last known activity
Feb 28, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 4 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (7)
- NCT05241912Lead sponsorEarly Phase 1Feb 28, 2022
- NCT05241912Reponsible party - principal investigatorEarly Phase 1Feb 28, 2022
- NCT05159947CollaboratorPhase 3Dec 31, 2021
- NCT03917004Sponsor investigatorN/AApr 1, 2019
- NCT03917004Lead sponsorN/AApr 1, 2019
- NCT03917004Study directorN/AApr 1, 2019
- NCT00548223CollaboratorPhase 4Dec 1, 2007
Details
- Last known activity
- Feb 28, 2022